A method of treating acute myeloid leukemia (AML) and multiple myeloma (mm) by administering an effective amount of a cell population including natural killer cellsCell populations containing natural killer cellsA three-stage method involving the step of cultivating a population of hematopoietic stem ...
How I treat acute myeloid leukemia. More than one quarter of a million adults throughout the world are diagnosed annually with acute myeloid leukemia (AML). Despite considerable progress duri... JM Rowe,MS Tallman - 《Blood》 被引量: 246发表: 2010年 How I treat acute and chronic leukemia...
Retinoid Therapy for Acute Promyelocytic Leukemia: A Coming of Age for the Differentiation Therapy o... Non-acute promyelocytic leukemia variant, acute myeloid leukemia with translocation (11;17) Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking a... Az...
Treatment of relapsed or refractory acute myeloid leukemia (AML) has presented challenges for hematologists for decades. Despite numerous clinical studies, outcomes are consistently disappointing with 5-year overall survival rates of approximately 10%. Allogeneic hematopoietic cell transplantation at the ...
APL is a subtype of acute myeloid leukemia (older M3 FAB) with a very high incidence of pre-treatment mortality. The t(15;17) (q22;q21), occurring in the majority of APL cases, determines PML::RARA rearrangement, which encodes for the PML/RAR alpha fusion protein able to stop myeloid ...
MLLmyeloid/lymphoid leukemia MLLMultimedia Learning Lab MLLMedical Lessons Learned(US Navy) MLLMaple Leaf Lounge(restaurant; Canada) MLLMillbrook Press, Inc.(former stock symbol; now MILB) MLLMaersk Lines, Limited MLLMinimum Luminance Level(plasma TVs) ...
New treatments for acute myeloid leukemia: how much has changed?doi:10.1038/s41375-020-01084-2Elihu EsteyLeukemia
Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML). The prognosis of APL is changing, from the worst among AML as it used to be, to currently the best. The application of all-trans-retinoic acid (ATRA) to the induction therapy of APL decreases the mor...
AML, acute myeloid leukemia; GM, galactomannan; ID, infectious disease; PCR, polymerase chain reaction; WBC, white blood cell. Back to our patient Our patient is a 65-year-old man with acute leukemia and probable IPA who has obesity, type 2 diabetes mellitus, and chronic renal insufficiency...
What is the prognosis for acute leukemia? How long do leukemia symptoms last? How effective is radiation therapy for leukemia? Is aplastic anemia leukemia? How are stem cells used to treat leukemia? How does lymphocytic leukemia disrupt normal cell communication? What is chronic myeloid leukemia?